Division of Urology, Hospital for Sick Children, University of Toronto, Ontario, Canada.
J Urol. 2010 Oct;184(4 Suppl):1638-43. doi: 10.1016/j.juro.2010.03.126. Epub 2010 Aug 21.
In patients with Wilms tumor indications for adrenalectomy are not well-defined. Following the rationale for preserving the adrenal gland in cases of other renal malignancies we determined predictors of adrenal involvement and the impact of adrenalectomy on retroperitoneal recurrence.
We retrospectively reviewed the record of patients who underwent surgical resection as primary treatment for Wilms tumor between 1990 and 2008 at 2 Canadian pediatric centers. Patient and tumor characteristics were reviewed to determine potential links to adrenal involvement. Recurrence was evaluated as a time dependent variable based on followup duration.
Of 180 patients diagnosed with Wilms tumor 95 underwent initial radical nephrectomy. Mean ± SD age at diagnosis was 46 ± 38 months and mean survival followup was 189 ± 8.3 months. Disease was stage 1 to 4 in 28, 34, 23 and 4 patients, respectively. Adrenalectomy was done in 58 patients (61%). Only 1 adrenal gland was reportedly positive for tumor invasion while peri-adrenal fat involvement was noted in 3 patients. No studied patient or tumor characteristics predicted involvement. No statistically significant difference in retroperitoneal recurrence was found between the groups in which the adrenal gland was removed vs preserved.
Adrenal involvement in patients with Wilms tumor is rare and difficult to predict. Preserving the adrenal gland was not associated with an increased risk of local recurrence. Thus, it seems prudent to avoid adrenalectomy at radical nephrectomy when technically feasible, instead attempting to otherwise remove all peri-adrenal fat with the specimen.
在患有肾母细胞瘤的患者中,肾上腺切除术的适应证尚未明确。基于保留其他肾脏恶性肿瘤中肾上腺的原理,我们确定了肾上腺受累的预测因素,以及肾上腺切除术对腹膜后复发的影响。
我们回顾性分析了 1990 年至 2008 年在加拿大 2 家儿科中心接受手术切除作为原发性治疗的肾母细胞瘤患者的记录。回顾患者和肿瘤特征,以确定与肾上腺受累的潜在联系。根据随访时间,将复发评估为一个时间相关的变量。
在 180 例诊断为肾母细胞瘤的患者中,95 例接受了初始根治性肾切除术。诊断时的平均年龄为 46 ± 38 个月,平均生存随访时间为 189 ± 8.3 个月。疾病分期分别为 1 期、3 期、2 期和 4 期患者各 28 例、34 例、23 例和 4 例。58 例患者(61%)行肾上腺切除术。仅 1 例肾上腺报道有肿瘤侵犯,3 例患者有肾上腺周围脂肪受累。未发现研究的患者或肿瘤特征可预测受累情况。在切除与保留肾上腺的两组之间,腹膜后复发无统计学显著差异。
肾母细胞瘤患者的肾上腺受累罕见且难以预测。保留肾上腺与局部复发风险增加无关。因此,在技术上可行的情况下,在根治性肾切除术中避免行肾上腺切除术,而试图切除标本中所有的肾上腺周围脂肪,似乎是明智的。